The social and clinical characteristics of patients on antiretroviral therapy who are 'lost to follow-up' in KwaZulu-Natal, South Africa: a prospective study
OUTPUT TYPE: Journal Article
PUBLICATION YEAR: 2012
TITLE AUTHOR(S): K.Peltzer, S.Ramlagan, M.S.Khan, B.Gaede
KEYWORDS: ANTIRETROVIRAL THERAPY (ART), HIV/AIDS, KWAZULU-NATAL PROVINCE
DEPARTMENT: Public Health, Societies and Belonging (HSC)
Print: HSRC Library: shelf number 7129
HANDLE: 20.500.11910/3501
URI: http://hdl.handle.net/20.500.11910/3501
If you would like to obtain a copy of this Research Output, please contact Hanlie Baudin at researchoutputs@hsrc.ac.za.
Abstract
A significant proportion of those initiating antiretroviral treatment (ART) for HIV infection are lost to follow-up. Causes (including HIV symptoms, quality of life, depression, herbal treatment and alcohol use) for discontinuing ART follow-up in predominantly rural resource-limited settings are not well understood. This is a prospective study of the treatment-naive patients recruited from three (one urban, one-semi-urban and one rural) public hospitals in Uthukela health district in KwaZulu-Natal from October 2007 to February 2008. The aim of this study was to investigate predictors of loss to follow-up or all caused attrition from an ART programme within a cohort followed up for over 12 months. A total of 735 patients (217 men and 518 women) prior to initiating ART completed a baseline questionnaire and 6- and 12-months' follow-up. At 12-months follow-up 557 (75.9%) individuals continued active ART, 177 (24.1%) were all cause attrition, there were 82 deaths (13.8%), 58 (7.9%) transfers, 7 (1.0%) refused participation, 8 (1.1%) were not yet on ART and 22 (3.0%) could not be traced. Death by 12-months of follow-up was associated with lower CD4 cell counts (risk ratio, RR=2.05, confidence intervals, CI=1.20 - 3.49) and higher depression levels (RR=1.05, CI=1.01 - 1.09) at baseline assessment. The high early mortality rates indicate that patients are enrolling into ART programmes with far too advanced immunodeficiency; median CD4 cell counts 119 (IQR=59 - 163). Causes of late access to the ART programme, such as delays in health care access (delayed health care seeking), health system delays, or inappropriate treatment criteria, need to be addressed. Differences in health status (lower CD4 cell counts and higher depression scores) should be taken into account when initiating patients on ART. Treating depression at ART initiation is recommended to improve treatment outcome.-
Related Research Outputs:
- Use of traditional complementary and alternative medicine for HIV patients in KwaZulu-Natal, South Africa
- Traditional complementary and alternative medicine and antiretroviral treatment adherence among HIV patients in KwaZulu-Natal, South Africa
- Antiretroviral treatment adherence among HIV patients in KwaZulu-Natal, South Africa
- Traditional complementary and alternative medicine and antiretroviral treatment adherence among HIV patients in KwaZulu-Natal, South Africa
- Perceived stigma among patients receiving antiretroviral therapy: a prospective study in KwaZulu-Natal, South Africa
- Antiretrovirals and the use of traditional, complementary and alternative medicine by HIV patients in KwaZulu-Natal, South Africa: a longitudinal study
- Design and methods of a longitudinal study investigating the impact of antiretroviral treatment on the partnerships and sexual behaviour of HIV-infected individuals in rural KwaZulu-Natal, South Africa
- The influence of antiretroviral treatment on willingness to test: a qualitative study in rural KwaZulu-Natal, South Africa
- Adherence to antiretroviral therapy in low socioeconomic status community sample
- Sexual dissatisfaction and associated factors in a sample of patients on antiretroviral treatment in KwaZulu-Natal, South Africa
- Spirituality and religion in antiretroviral therapy (ART) in KwaZulu-Natal, South Africa: a longitudinal study
- Health related quality of life and antiretroviral treatment in patients over a period of 20 months in KwaZulu-Natal, South Africa
- Efficacy of a lay health worker led group antiretroviral medication adherence training among non-adherent HIV-positive patients in KwaZulu-Natal, South Africa: results from a randomized trial
- Health-related quality of life and antiretroviral therapy in KwaZulu-Natal, South Africa
- Social grants for people with HIV and on antiretroviral therapy in KwaZulu-Natal, South Africa: a longitudinal study
- Efficacy of a lay health worker led group antiretroviral medication adherence training among non-adherent HIV-positive patients in KwaZulu-Natal, South Africa: results from a randomized trial
- The South African disability grant: influence on HIV treatment outcomes and household well-being in KwaZulu-Natal
- HIV-related symptoms and management in HIV and antiretroviral therapy patients in KwaZulu-Natal, South Africa: a longitudinal study
- Initiation of antiretroviral therapy and viral suppression after home HIV testing and counselling in KwaZulu-Natal, South Africa, and Mabarara district, Uganda: a prospective, observational intervention study
- The impact of HIV/AIDS on land issues in Kwazulu-Natal province South Africa: case studies from Muden, Dondotha, Kwadumisa and Kwanyuswa